{
    "2021-11-15": [
        [
            {
                "time": "2022-11-15",
                "original_text": "Glaxo (GSK), Vir Intramuscular Sotrovimab Meets Study Endpoint",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "GSK",
                        "Vir",
                        "Intramuscular",
                        "Sotrovimab",
                        "Study Endpoint"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}